Skip to main content
VREX logo

VREX · Varex Imaging Corp

Track VREX — free
$18.46 +0.00 (+0.00%)
Market Cap
$776.75M
Shares
42.10M
Volume · Oct 5 298.08K Avg daily vol (3M) 830.67K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$18.46 Open$18.50 Day$18.46–18.50 52W close$9.32–18.58 Avg vol 30d662K Short int1.4M · 3.3% float · 1.9d Short vol66% Last earningsAug 10, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 10

Up next

Next earnings call
Nov 9, 2026 Est · unconfirmed · in 5 wks
filed Aug 10, 2026
call held May 7, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$865.00M
Trailing 12 months
Net income (TTM)
$22.10M
Trailing 12 months
Revenue growth YoY
+3.7%
Year over year
Operating margin
8.3%
Trailing 12 months
P / E (TTM)
35.5
Trailing earnings · reciprocal yield 2.8%
FCF yield
-2.6%
TTM · current market cap
Return on invested capital
7.9%
Trailing 12 months
Net cash
−$247.90M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2.7%
Year over year · more shares
Price change (1Y)
+55.6%
Trailing year
Short interest
3.3%
Latest settlement · 1.9 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Weak Quant / Vol Moderate
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +42%
above
Price vs 50-day avg +9%
above
RSI (14) 76
overbought
MACD trend Negative
52-week position 99%
near high
Momentum
relative strength
Very Strong
1-month return 0%
trailing
6-month return +62%
trailing
YTD return +58%
this year
Relative strength +49%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $17 › 200d $13 — 50d above 200d
Institutional flow Accumulating
2 of 186 funds reported for Sep 30 · net +34 sh shares
Insider flow Distributing
Net -$2.6M over 90 days · 100% sells
Short interest Rising
3.34% of float · ▲ +12.1% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
186 holders — mid 3-yr range
Squeeze score 51
elevated · 0–100
Fundamentals
Weak
Revenue growth −9%
Y/Y
Gross margin 36%
expanding
EPS growth −42%
Y/Y
Free cash flow $18.8M
Valuation P/E 35.5
rich
Balance sheet $222.5M
net debt
Quant / Vol
risk profile
Moderate
Volatility 64%
annualized · 1-yr
Max drawdown −35%
past year
ATR 0.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 7 of last 8
Latest guidance · from the 8-K filed May 7, 2026
Revenue · full fiscal year 2026 Initiated $860M – $880M
prior FY $844.6M midpoint +3.0% Y/Y
Non-GAAP EPS · full fiscal year 2026 Non-GAAP Initiated $0.80 – $1.00
Prior guidance period ended · from the 8-K filed May 7, 2026
Revenues · third quarter of fiscal year 2026 $210M – $225M
Non-GAAP net earnings per diluted share · third quarter of fiscal year 2026 $0.15 – $0.30
Guided vs delivered · last 8 settled
Revenues third quarter of fiscal year 2026
guided $210M – $225M
$210.5M In line
Revenues fourth quarter of fiscal year 2024
guided $190M – $210M
$205.7M In line
Revenues third quarter of fiscal year 2024
guided $200M – $220M
$209.1M In line
Revenues first quarter of fiscal year 2024
guided $180M – $200M
$190M In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
2 · 1 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+42% Bullish
Price vs 50-day avg
+9% Bullish
RSI (14)
76 Bearish
MACD trend
Negative Bearish
52-week position
99% Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $17 › 200d $13 — 50d above 200d
Institutional flow Accumulating
2 of 186 funds reported for Sep 30 · net +34 sh shares
Insider flow Distributing
Net -$2.6M over 90 days · 100% sells
Short interest Rising
3.34% of float · ▲ +12.1% MoM · 1.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
186 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $9 Now $18 · 99% Range high $19
vs 200-day avg +42% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Cash flow from operations $21M Q3FY26 —
Industrial gross margin 37.1% the three months ended July 3, 2026 filing —
Non-GAAP diluted net income per share non-GAAP $0.71 Nine Months Ended July 3, 2026 —
Non-GAAP gross margin non-GAAP 34.7% Nine Months Ended July 3, 2026 —
Non-GAAP operating margin non-GAAP 11.6% Three Months Ended July 3, 2026 —
Research and development as a percentage of total revenues, net 11.1% the three months ended July 3, 2026 filing —
Selling, general, and administrative as a percentage of total revenues, net 14.5% the three months ended July 3, 2026 filing —
Total gross margin 36.4% the three months ended July 3, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
VREX
Varex Imaging Corp
this stock
$776.75M +58.5% -9.2% 35.5 3.3%
ABT
Abbott Laboratories
$174.90B -22.2% +5.7% 28.1 1.1%
MDT
Medtronic plc
$113.38B -10.1% +8.4% 21.8 1.3%
SYK
Stryker Corp
$104.47B -21.6% +11.2% 28.2 2.0%
BSX
Boston Scientific Corp
$63.59B -55.3% +12.5% 17.8 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
185
% held
95.5%
Reported
2 of 186
Top holder
PZENA INVESTMENT MANAGEME…
Held Float
View
Held by Funds
Fund positions
233
View
Short & Settlement
Short Interest Rising
Shares short
1.4M
Days to cover
1.9d
Change
+151.5K sh
View
Short Volume
Short vol %
66%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
466
Value
$8.6K
As of
Aug 11, 2026
View
Off-Exchange
Off-exchange %
48.6%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$2.6M
Buyers / Sellers
0 / 2
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$844.6M
Net income (FY)
$-70.3M
EPS diluted
$-1.70
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 10, 2026
This year
9
View
Proposed Sales
Value
$150.1K
Shares
8.1K
Filed
Sep 14, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 10, 2026
View

Performance

5D 20D 120D MTD YTD
VREX +0.1% -0.3% +61.7% +0.1% +58.5%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY +0.3% +0.1% +49.5% -0.9% +45.6%
Key facts CIK 1681622 CUSIP 92214X106 13F (30d) 7 filings 5 filers Visit website Investor relations